Diese Veranstaltung hat bereits stattgefunden

Web-Seminar

Retina Society 2020 VR (with 2 pre-meetings Aug25&Sep08)

53rd Annual Scientific Meeting
online, Großbritannien
Veranstaltungsnummer: 33466
Zertifizierung: beantragt
Gebühren ab: 0,00 GBP
verfügbare Plätze: unbegrenzt
Sprache: Englisch

 Zum Kalender hinzufügen
  • Datum
    21.09.2020, 20:00 - 22.09.2020, 22:00
    Veranstalter
    The Retina Society
    Kurzbeschreibung
    The Retina Society 2020 VR Live will be dynamic, interactive, and a new digital platform to connect colleagues, to discuss and debate interesting cases and surgical challenges, to learn from award-winning honorees and to envision the new future of Retina in delivery of care, education and translational clinical research. It will be an enduring on-demand digital platform for pre-recorded Abstract, Poster, Interesting Case and Surgical Video presentations.
    Hinweis
    The Retina Society 2020 VR will offer CME credits.
    Gebühren

    Fachärzte

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    0,00 GBP
    Hinweis
    Retina Society 2020 VR registration will be open to all MDs and physicians-in-training and not restricted to Retina Society members only.

    Ärzte/-innen in Weiterbildung

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    0,00 GBP
    Hinweis
    Retina Society 2020 VR registration will be open to all MDs and physicians-in-training and not restricted to Retina Society members only.

    medizinisches Fachpersonal

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    0,00 GBP
    Hinweis
    Retina Society 2020 VR registration will be open to all MDs and physicians-in-training and not restricted to Retina Society members only.

    Sonstige

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    0,00 GBP
    Hinweis
    Retina Society 2020 VR registration will be open to all MDs and physicians-in-training and not restricted to Retina Society members only.

    Industriemitarbeiter/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    0,00 GBP
    Hinweis
    Retina Society 2020 VR registration will be open to all MDs and physicians-in-training and not restricted to Retina Society members only.
    Deadlines

    Abstract

    18.05.2020 Hinweis
    The Retina Society 2020 Virtual Abstract, Interesting Case and Video Submissions, and the Retina Research Fellowship Award and Margherio Fellows Award deadlines have all been extended to Monday, May 18, 2020. Abstract submission is for members, their sponsored guests, and member-sponsored fellows only. The Sponsor and Digital Exhibitors deadline is extended to July 1, 2020.
  • Spotlight

    Tuesday, August 25, 8:00–9:30 pm ET

    Pre-Meeting 1: New Member Spotlight

    Tuesday, August 25, 8:00–9:30 pm ET

    Welcome & Announcements

    Program Committee

    Session 1.1: Age-related Macular Degeneration: A Focus on Durability

    Moderator: David Brown, MD

    Panelists: Anita Agarwal, MD; Emily Chew, MD; Bailey Freund, MD; Joo Yong Lee, MD, Charles Wykoff, MD

    Presenters: David Eichenbaum, MD; Arshad Khanani, MD; Benjamin Kim, MD

    Key Learnings From the Phase 2 Ladder Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD

    David Eichenbaum, MD

    Updated Results of Phase 1b Study of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate w Durability, in wAMD, DME, and RVO

    Arshad Khanani, MD

    Prolonged Intraocular Residence of a Fourth Generation Compstatin Complement C3 Inhibitor Supports Its Clinical Development for GA

    Benjamin Kim MD

    Live Panel Q/A

    Mrinali Gupta, MD

    Session 1.2: Potpourri: Diabetes, Imaging & Inflammation 

    Moderator: SriniVas Sadda, MD

    Panelists: Brandon Lujan, MD; David Sarraf, MD; Eliott Sohn, MD; Kimberly Stepien, MD; Akitaka Tsujikawa, MD

    Presenters: Dilraj Grewal, MD; Satoru Kase, MD; Ajay Kuriyan, MD; Zofia Michalewska, MD; Andreas Pollreisz, MD

    Correlation of Macular Vessel Density and Vision in Proliferative Diabetic Retinopathy: Development and Application of an Automated Deep Neural Network for Fluorescein Angiography Vessel Detection

    Ajay Kuriyan, MD

    Longitudinal Changes of Microvascular Perfusion and Neurodegeneration in Early Type 2 Diabetic Retinal Disease

    Andeas Pollreisz, MD

    Swept Source OCT Angiography in Eyes After Scleral Buckling

    Zofia Michalewska, MD, PhD

    Choroidal Macrovessel: A Multimodal Imaging Analysis

    Satoru Kase, MD

    Evaluating the True Rate of Recurrence of Non-Infectious Posterior Segment Uveitis Following Treatment with an Injectable FA insert

    Dilraj Grewal, MD

    Live Panel Q/A

    Mrinali Gupta, MD

    Session 1.3: Fellow Award 

    Moderator: Prithvi Mruthyunjaya, MD

    Panelists: Amani Fawzi, MD; Deeba Husain, MD

    Margherio Awardee Presentation: Progression of Geographic Atrophy with Subsequent Exudative Neovascular Disease in Age-related Macular Degeneration: AREDS2 Report 23

    Christopher Hwang, MD

    Panelists

    Emily Chew, MD; Christopher Hwang, MD; Prithvi Mruthyunjaya, MD

    Live Panel Q/A

     

    Session 1.4: Surgery with the Next Generation of Vitreoretinal Surgical Stars

    Moderator: Kourous Rezai, MD

    Panelists: Peter Campbell, MD; Steve Charles, MD; Kimerbly Drenser, MD, Eric Nudleman, MD, Kirk Packo, MD

    Presenters: Lisa Faia, MD; Ali Khan, MD; Michael Klufas, MD; Jayanth Sridhar, MD; Yoshihiro Yonekowa, MD

    Clinical Outcomes in Bilateral Sequential Rhegmatogenous Retinal Detachment

    Michael Klufas, MD

    Characteristics and Surgical Outcomes of Rhegmatogenous Retinal Detachment in Elderly Patients

    Yoshihiro Yonekawa, MD

    ERM Surgery Following Prior Primary RRD Repair: Optical Coherence Tomography Features and Surgical Outcomes

    Ali Khan, MD

    Lens and Peripheral Retinal Relationships During Vitrectomy: Comparison of 23, 25, and 27-gauge Vitrectomy and Curved Endolaser pProbes

    Jayanth Sridhar, MD

    Long-Term Outcomes of Sutureless Intrascleral Fixation of Intraocular Lens with Pars Plana Vitrectomy in Patients with Posterior or Panuveitis

    Lisa Faia, MD

    Live Panel Q/A

    Mrinali Gupta, MD

    Pre-Meeting 2: Clinical Trials - The Cutting Edge

    Tuesday, September 8, 8:00–9:30 pm ET

    Welcome and Announcements

    Program Committee

    Session 2.1.1: Trials on the Edge - Can We Raise the Bar for AMD?

    Moderators: Jennifer Lim, MD; David Zacks, MD

    Panelists: Susan Bressler, MD; Carl Csaky, MD; Dante Pieramici, MD

    Author Panelists:  Sumit Shah, MD; Robert Avery, MD; Eleanora Lad, MD; Glenn Jaffe, MD

    Prophylaxis Intravitreal Aflibercept against Conversion to Neovascular Age-Related Macular Degeneration in High Risk Eyes (PRO-CON): 24 Month Results

    Sumit Shah, MD

    Preliminary Findings from a Phase 1 Trial Evaluating the Safety, Tolerability and Biological Activity of OTX-TKI, a Hydrogel-Based, Sustained-Release Intravitreal Axitinib Implant, in Subjects with Neovascular Age-Related Macular Degeneration (nAMD)

    Robert Avery, MD

    Effect of Dual Angiopoietin-2/VEGF-A Inhibition with Faricimab on Macular Anatomy in the STAIRWAY Ph2 Study of nAMD

    Eleanora Lad, MD

    Macular Atrophy (MA) in the Phase 2 Ladder Trial

    Glenn Jaffe, MD

    Live Panel Q/A

     

    Session 2.1.2: Trials on the Edge - Diabetes and More 

    Moderators: Shlomit Schaal, MD; Cynthia Toth, MD

    Panelists: Lloyd Aiello, MD,  Jennifer Sun, MD

    Author Panelists:  Nathan Steinle, MD, Ingrid Scott, MD, Pauline Merrill, MD

    Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA

    Nathan Steinle, MD 

    Study of COmparative Treatments in REtinal Vein Occlusion 2 (SCORE2) Month 48 Results

    Ingrid Scott, MD

    Results from the Phase 3 PEACHTREE Clinical Trial: Systemic Therapy and the Efficacy of CLS-TA, a Post-Hoc Analysis

    Pauline Merrill, MD

    Live Panel Q/A

     

    Session 2.2: Retina Society Fellow Research Award

    Moderator: Prithvi Mruthyunjaya, MD

    Retina Research Awardee: Elizabeth Rossin, MD, PhD; Presentation:  Structure-based network analysis of viral proteins reveals potential epitopes for vaccine targeting in SARS-CoV-2
    Sponsor: Lucia Sobrin, MD

    Mentor: Gaurav Gaiha, MD

    Panelists: Rajendra Apte, MD; Gaurav Gaiha, MD; Elizabeth Rossin, MD, PhD; Adrienne Scott, MD

    Live Panel Q&A

     

    Session 2.3: Pediatrics 

    Moderator: Antonio Capone, MD

    Panelists: Paul Chan, MD; Philip Ferrone, MD; Baker Hubbard, MD; Thomas Lee, MD

    Author Panelists: Nina Berrocal, MD; Cynthia Toth, MD; Kim Jiramongkolchai, MD

    Retinoschisis in Coats Disease

    Nina Berrocal, MD 

    Macular OCT Characteristics at 36 weeks Postmenstrual Age in a Cohort of Preterm Infants Examined for Retinopathy of Prematurity

    Cynthia Toth, MD

    Lower Fetal Hemoglobin Levels at 31- and 34-weeks Postmenstrual Age is Associated with the Development of Retinopathy of Prematurity

    Kim Jiramongkolchai, MD

    Live Panel Q/A

     

    Session 2.4.1: Trials on the Edge - Promising Translational Advances 

    Moderators: Jennifer Lim, MD; Andrew Schachat, MD

    Panelists: Aaron Nagiel, MD; Thiran Jayasundara, MD

    Author Panelists:  David Zacks, MD; Baruch Kuppermann, MD; Jose-Alain Sahel, MD; Stephen Russell, MD

    Absence of Fas receptor signaling reduces photoreceptor cell death and improves retinal function in a mouse model of P23H auto dominant RP

    David Zacks, MD

    Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells for the Treatment of RP: A Prospective Randomized Controlled Phase 2

    Baruch Kuppermann, MD

     

    Signs of functional vision recovery in an advanced stage RP patient after optogenetic therapy

    Jose-Alain Sahel, MD

    Five-year update for the phase 3 voretigene neparvovec-rzyl study in biallelic RPE65 mutation associated inherited retinal disease

    Stephen Russell, MD

    Live Panel Q/A

     

    Session 2.4.2: Trials on the Edge - Focus on Gene Therapies

    Moderators: Szilard Kiss, MD, Cynthia Toth, MD

    Panelists: Peter Campochiaro, MD, Christine Kay, MD, Mark Pennesi, MD

    Author Panelists: Ninel Gregori, MD, Joseph Martel, MD, Brian Joondeph, MD, Nancy Holekamp, MD

    Choroideremia Gene Therapy: Phase 2 Clinical Trial 48 Month Results and Overview

    Ninel Gregori, MD

    First Results of a Photovoltaic Subretinal Prosthesis for Restoration of Central Vision in Atrophic Dry Age-Related Macular Degeneration in the United States

    Joseph Martel, MD

    ADVM-022 Intravitreal Gene Therapy for Neovascular AMD -  Phase 1 OPTIC Study Update

    Brian Joondeph, MD

    Suprachoroidally delivered non-viral DNA nanoparticles transfect chorioretinal cells in non-human primates and rabbits

    Nancy Holekamp, MD

    Live Panel Q/A

     

    Meeting 3: RS2020 VR Live

    Monday, September 21, 8:00–10:00 pm ET

    Session 3.1: Interpreting Signals for AMD Therapies

    Moderators: Sunir Garg, MD; Steven Yeh, MD

    Panelists: Richard Kaiser, MD; Darius Moshfeghi, MD

    Author Panelists: Daniel Roth, MD; Andre Witkin, MD; Caroline Baumal, MD; Thomas Albini, MD

    Reduced Incidence of Post-Injection Endophthalmitis with Pre-filled Syringes

    Daniel Roth, MD

    Occlusive retinal vasculitis following intravitreal brolucizumab for exudative age-related macular degeneration

    Andre Witkin, MD

    Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab

    Caroline Baumal

    Abicipar Phase 2 MAPLE Trial Demonstrates Improved Safety for Patients with nAMD Following a Modified Manufacturing Process

    Thomas Albini, MD

    Live Panel Q&A

     

    Session 3.2.1: Medical Controversy: Which Anti  VEGF Agent do I choose?

    Moderators: Jeffrey Heier, MD; Allen Ho, MD

    Panelists: Jason Hsu, MD; Reginald Sanders, MD

    Author Panelists: Peter Kaiser, MD; David Lally, MD; Diana Do, MD

    Visual and anatomical outcomes by q12w/q8w status in the HAWK and HARRIER studies of brolu. versus aflibercept in neovascular AMD

    Peter Kaiser, MD

    A comparison of the efficacy of brolu and aflibercept in eyes with early persistent retinal fluid: 96-week results from the HAWK and HARRIER studies

    David Lally, MD

    Absence of Safety Signal for Occlusive Retinal Vasculitis with Intravitreal Aflibercept Injection

    Diana Do, MD

    Live Panel Q&A 

     

    Session 3.2.2: Retinal Detachment Surgical Controversy: SB, PPV or Something Else?

    Moderators:  Mark Johnson, MD; Judy Kim, MD

    Panelists: Edwin Ryan, MD; Michael Trese, MD; Lejla Vajzovic, MD

    Author Panelists: Susanna Park, MD; Thomas Wubben, MD; Rajeev Muni, MD

    Interesting Case - Unexplained progressive vision loss after successful retinal detachment repair

    Susanna Park, MD

    Pars plana vitrectomy versus combined pars plana vitrectomy-scleral buckle versus scleral buckle for repair of primary RRD

    Thomas Wubben, MD

    Retinal Displacement following Pneumatic Retinopexy vs Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment (ALIGN STUDY)

    Rajeev Muni, MD

    Live Panel Q/A

     

    Sessions 3.3: The Evolution of Vitreoretinal Surgery 

    Moderators:  Donald D’Amico, MD; George Williams, MD

    Panelists: Stanley Chang, MD; Thomas Aaberg Jr, MD

    Author Panelists: Nicole Koulisis, MD; Christina Weng, MD; Natalia Figueiredo, MD; Rahul Khurana, MD; Mauricio Maia, MD

    Functional and Anatomic Outcomes of the … Consortium of Autologous Retinal Transplantation for Primary, Refractory, and Macular Hole Retina 

    Nicole Koulisis, MD

    Autologous Retinal Transplant in a Macular Hole-associated Total Rhegmatogenous Retinal Detachment 

    Surgical Video - Christina Weng, MD

    Interesting Case - Paracentral Scotoma after Pars Plana Vitrectomy for Rhegmatogenous Retinal Detachment

    Rahul Khurana, MD

    Longitudinal Assessment of Ellipsoid Zone Recovery using En Face OCT after Retinal Detachment Surgery

    Natalia Figueiredo, MD

    Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery

    Mauricio Maia, MD

    Live Panel Q/A

     

    Session 3.4: Retinal Research Foundation Award / Schepens Lecture

    Moderator and Introductions: Bernard Doft, MD; Paul Sternberg, MD

    Awardee: Russell Van Gelder, MD, PhD - Prospects for vision restoration in outer retinal degeneration

    Panelists: Harry Flynn, MD; Joan Miller, MD; Jose Pulido, MD

    Live Panel Q/A 

     

    Session 3.5: New Tools and Techniques Vitreoretinal Surgery

    Moderators: Dean Eliott, MD; Tarek Hassan, MD

    Panelists: David Chow, MD; Gaurav Shah, MD

    Author Panelists: Maria Berrocal, MD; Tomasz Stryjewski, MD; Scott Walter, MD; Yanneck Leiderman, MD; Prithvi Mruthyunjaya, MD

    Retinal Detachment Repair with 27g Vitrectomy with 20,000 c/m Probe

    Surgical Video- Maria Berrocal, MD

    PYK-1105: Pre-Clinical Evaluation Of A Novel Biodegradable Vitreous Substitute For Retinal Tamponade

    Tomasz Stryjewski, MD

    Management of Proliferative Vitreoretinopathy with Intravitreal Methotrexate using a Treat-and-Extend Protocol

    Scott Walter, MD

    Surgical Guidance in Pars Plana Vitrectomy Using Deep Learning and Computer Vision 

    Yannek Leiderman

    The Exudative and Rhegmatogenous Retinal Detachment:  Getting Answers

    Surgical Video - Prithvi Mruthyunjaya, MD

    Live Panel Q/A

     

    Session 3.6: The Promising AMD Drug and Technology Pipeline

    Moderators: David Boyer, MD; Peter Kaiser, MD

    Panelists:  Alice Lyon, MD; Alexander Brucker, MD

    Author Panelists: Carl Regillo, MD; Allen Chiang, MD; David Brown, MD; Anat Loewenstein, MD

    Avacincaptad Pegol, A Novel C5 Inhibitor, Significantly Reduces the Mean Rate of Geographic Atrophy Growth in a Pivotal  Clinical Trial

    Carl Regillo, MD

    Assessment of Progression of Geographic Atrophy in the FILLY Study

    Allen Chiang, MD

    Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD)

    David Brown, MD

    Usability and Quality of Retinal Images Captured by a Self-Operated, Home-based Optical Coherence Tomography (OCT) System

    Anat Loewenstein, MD 

    Live Panel Q/A 

     

    Meeting 4: RS2020 VR Live  

     Tuesday, September 22, 8:00–10:00 pm ET

      Session 4.1: Oncology 2020

    Moderators: Ivana Kim, MD; Tara McCannel, MD

    Author Panelists: David Abramson, MD; Anthony Daniels, MD; Carol Shields, MD; Prithvi Mruthyunjaya, MD; Timothy Murray, MD

    Circumscribed choroidal hemangioma: Visual outcome in the pre-photodynamic therapy (PDT) vs PDT eras in 458 cases

    Carol Shields, MD

    Treatment of Retinoblastoma Patients with 13q Deletion Syndrome in the Intrarterial and Intravitreal Era

    David Abramson, MD

    Vitreous proteomics correlates with gene expression profiling in uveal melanoma

    Prithvi Mruthyunjaya, MD 

    Vitreoretinal Surgical Management of Small Choroidal Melanoma: 5-year outcomes in patients avoiding radiotherapy

    Timothy Murray, MD 

    Impact of different initial systemic staging imaging strategies on metastasis …: The Melanoma of the Uvea Staging Imaging Consortium (MUSIC)

    Anthony Daniels, MD

    Live Panel Q/A

     

    Session 4.2  Late Breakers: Age-related Macular Degeneration and Diabetic Retinopathy

    Moderators:  Mark Blumenkranz, MD, Allen Ho, MD

    Panelists: Jorge Arroyo, MD, Ivan Suner, MD

    Author Panelists: Carl Awh, MD, Charles Wykoff, MD, Hani Salehi-Had, MD, Jeffrey Heier, MD

    Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System with Ranibizumab (PDS) for Patients With nAMD

    Carl Awh, MD

    Gene Therapy with RGX-314 for Neovascular AMD: New Results from the Ongoing Phase I/IIa Study

    Charles Wykoff, MD

    Intraocular Inflammation, Vasculitis & Vascular Occlusion in the HAWK & HARRIER Trials: Findings of the Safety Review Committee

    Jeffrey Heier, MD

    Effect of  Vitrectomy and Panretinal Photocoagulation versus Intravitreous Aflibercept on Visual Acuity in Patients with Vitreous Hemorrhage from Proliferative Diabetic Retinopathy:  A Randomized Clinical Trial

    Andrew Antoszyk, MD

    Session 4.3  RetinoVascular Correlations

    Moderators: Adrienne Scott, MD, Pat Wilkinson, MD

    Panelists: Peter Hovland, MD, Keith Warren, MD

    Author Panelists: Jennifer Lim, MD, Michael Ip, MD, Anita Agarwal, MD

    Live Panel Q/A

     

    Risk factors for retinal thinning in sickle cell versus control eyes: Analysis of a prospective study using SDOCT Imaging 

    Jennifer Lim, MD

    Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to RVO, Diabetic Retinopathy and Uveitis 

    Michael Ip, MD

    Retinal Vasculopathy in a 40-year-old female

    Anita Agarwal, MD

    Live Panel Q/A

     

     

    Session 4.4: The Retina Society Gass Award

    Introductions: Bernard Doft, MD; Stuart Fine, MD

    Awardees:  Maureen Maguire, PhD, FARVO, and Daniel Martin, MD:

    CATT Tales: 15 Years of Science, Politics, and Persistence

    Panelists: Robert Avery, MD, Neil Bressler, MD, Philip Rosenfeld, MD

    Live Panel Q/A 

     

     

    Session 4.5  The Evolving Paradigm for Diabetic Retinopathy

    Moderators:  Lloyd Aiello, MD, William Mieler, MD

    Panelist: Andrew Moshfeghi, MD, Jennifer Sun, MD

    Author Panelists: Quan Nguyen, MD, Sophia Bakri, MD, Ehsan Rahimy, MD, David Boyer, MD, Jason Hsu, MD

    Has the Time Come to Re-evaluate the Treatment Paradigm for Diabetic Retinopathy?

    Quan Nguyen, MD

    Clinical Significance of DR Improvement: A Meta-Analysis of Vision and Anatomic Outcomes in Five Clinical Trials Evaluating IVT Ranibizumab

    Sophie Bakri. MD

    Progression to Proliferative Diabetic Retinopathy in Nonproliferative Diabetic Retinopathy Eyes without Diabetic Macular Edema in the United States

    Ehsan Rahimy, MD

    Intravitreal Aflibercept Injection for Nonproliferative Diabetic Retinopathy: Results from the PANORAMA Study

    David Boyer, MD 

    Outcomes of Eyes with Diabetic Macular Edema that are Lost to Follow-up after Anti-Vascular Endothelial Growth Factor Therapy

    Jason Hsu, MD

    Live Panel Q/A

     

    Session 4.6  The Future of Retina and RS2020VR Highlights

    Moderators: Jeffrey Heier, MD; Allen Ho, MD

    Panelists: Julia Haller, MD; Mark Humayan, MD; David Parke, MD, Allison Shuren, JD, James Vander, MD;

    Author Panelists: Jiong Yan, MD; Itay Chowers, MD; Aleksandra Rachitskaya, MD

    Medical-Legal and Ethical Considerations During the COVID-19 Pandemic

    Jiong Yan, MD 

    Interesting Case - Itay Chowers, MD - Risks of SARS-CoV-2 Transmission to Medical Staff and Patients froman Exposure to a COVID-19-Positive Ophthalmologist

     

    Provider Ratings and Patient, Disease, and Appointment Factors

    Aleksandra Rachitskaya, MD

    Live Panel Q/A

     

    END PROGRAM and ANNOUNCEMENTS

     

     

    Meeting Format and Content

    Meeting Format and ContentRetina Society 2020 VR Live events will be dynamic live stream events with Interesting Case and Surgical Video Panels with interactive discussion and debate, Hot Topics Panels, Special Symposia and Interviews during two consecutive evenings, exact times pending. Due to time limitations with live stream events, scientific content will also be available on-demand.
    Retina Society 2020 VR 24/7 will be on-demand and feature Retina Society Member, Sponsored Guests and Fellows narrated videos, PowerPoint / Keynote and Poster presentations. These presentations will be uploaded to the Retina Society 2020 VR Platform this summer (dates pending) for on-demand scientific and educational content for registered meeting attendees.
    Retina Society 2020 VR Retina Ecosystem Exhibition will connect attendees with our retina ecosystem partners and showcase the latest interventions, innovations and technologies.

     

    Awards

    Award of Merit in Retina Research

    The Award of Merit in Retina Research was created in 1978 by Retina Research Foundation, Houston, Texas, to recognize outstanding vision scientists whose work contributes to knowledge about the retina and retinal diseases. Each year, the Awardee is invited to give the Charles L. Schepens Lecture, a highlight of the Retina Society annual meeting that was established in honor of the founder of the Society.

    The award offers a $50,000 cash prize that includes a $5,000 honorarium and a $45,000 research grant. The recipient is chosen by the Awards Committee of the Retina Society. Funding for the award of Merit is provided by Retina Research Foundation through a series of endowed gifts that are dedicated to the Award.

    The Retina Research Foundation of Houston, Texas presents the Award of Merit in Retina Research to a vision scientist whose work represents:

    • A single outstanding achievement in retina research, or; 
    • A potentially significant contribution to new knowledge about the retina, its role in the visual process and/or vitreoretinal diseases or disorders.

    J. Donald M. Gass Lectureship

    In 2006, The Retina Society inaugurated the J. Donald M. Gass lectureship. He was a peerless observer of the fundus. His unique and repeated ability to identify fundamental patterns of disease from the mass of seemingly chaotic details invites sincere comparison to Michelangelo working in marble. 

    Fellowship Research Award

    The Retina Society Fellowship Research Award was established in 1996 to encourage academic pursuit in young vitreoretinal surgeons and to acquaint them with the scientific and social aspects of the Society. The applicant must be sponsored by an active member of the Retina Society. Each paper is judged on originality, quality of investigation methods, and merit of scientific contribution.

    Raymond R. Margherio Award

    The Raymond R. Margherio Endowed Memorial Fund was established to support research into macular disease and development of new techniques of macular surgery. The Fund will support an award to be presented annually to a vitreoretinal fellow of an Active Member of the Retina Society. The fellow will present his work at the Annual Meeting of the Retina Society. The winner is selected by the Research Award Committee.

  • This event will be virtual.

    The Retina Society
    Judy Cerone Keenan
    P.O. Box 6305
    US - 02114 Boston, MA
    Tel.: +1 617 227-8767
    Fax: +1 617 367-4908

  •  

    Unfortunately, you cannot book this event event on Eyefox yet. You should ask the organizer to be able to book quickly and easily on Eyefox.

    Do you know already? If you tick this event at My Events in your Member Area, you will be informed immediately when news become available!

     

     

    You are the organizer?

    Would you like to link your online registration here?

     

    Download the order form here and send it back to us via fax or email.